MedTrace Logo

Teriparatide Treatment in Patients With Inherited Osteoporosis

NCT01360424 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2015-09-29

No results posted yet for this study

Summary

The purpose of this study is to analyse efficacy of teriparatide treatment in patients with new forms of inherited low-turnover osteoporosis.

Conditions

Interventions

DRUG

Teriparatide

Daily administration of teriparatide 20 ug s.c. for 24 months

Sponsors & Collaborators

Principal Investigators

  • Matti Välimäki, MD,PhD · Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2013-11-30
Completion
2013-11-30

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01360424 on ClinicalTrials.gov